MediGene AG Reports Financial Results for the 2009 Fiscal Year
EBITDA loss EUR 18.8 million
30-Mar-2010 -
MediGene AG reported its results for the fiscal year 2009, and gave an outlook for the fiscal year 2010. According to the forecast, MediGene reduced the loss on an EBITDA basis in 2009, from approximately 25 million euros to approximately 19 million euros, with unchanged revenue of approximately ...
breast cancer
clinical trials
concrete
+6